Sapienza University of Rome

Technip Energies Announces Appointments to its Executive Committee

Retrieved on: 
Tuesday, January 23, 2024
Environment, Engineering, Chemicals, Plastics, Utilities, Oil, Gas, Manufacturing, Alternative Energy, Sustainability, Energy, Carbon, Region, Risk management, ERP, Yale School of Management, Yale school, BearingPoint, Executive Committee, HEC Paris, Engineering & Technology, CDIO, Export, TechnipFMC, Graduate diploma, Business, Internal audit, Digital, Sapienza University of Rome, Oracle, McKinsey & Company, École polytechnique, Technip Energies, Technique, Control, Negotiation, Information, Management

Technip Energies, a leading Engineering & Technology company for the energy transition, announces the following Executive Committee appointments:

Key Points: 
  • Technip Energies, a leading Engineering & Technology company for the energy transition, announces the following Executive Committee appointments:
    Naïla Giovanni, has been appointed to the newly created position of Chief Digital and Information Officer (CDIO), to accelerate Technip Energies’ digital transformation.
  • Based in Paris, she joins the Executive Committee.
  • Technip Energies also announces the appointment of Marco Villa, previously Chief Operating Officer, to the new position of Chief Business Officer within the Executive Committee.
  • In 2021, he became Chief Operating Officer of Technip Energies.

Rivian Hires Carlo Materazzo as Vice President, Logistics

Retrieved on: 
Monday, November 13, 2023
EV, Electric Vehicles, Alternative Vehicles, Fuels, Automotive, Other Transport, Automotive Manufacturing, General Automotive, Transport, Manufacturing, Carbon, Courage, Automotive industry, Logistics, Mechanical engineering, Sapienza University of Rome, Business administration, Lean, University, Production system, Fiat Chrysler Automobiles, Business, Mechanical, Rivian, Operation

Rivian Automotive, Inc. (NASDAQ: RIVN) today announced Carlo Materazzo as Vice President, Logistics.

Key Points: 
  • Rivian Automotive, Inc. (NASDAQ: RIVN) today announced Carlo Materazzo as Vice President, Logistics.
  • Materazzo, who starts at Rivian today, brings more than twenty years of experience in the automotive industry to reinforce Rivian’s journey towards excellence in manufacturing.
  • Before joining Rivian, Materazzo worked at Stellantis North America as VP of Manufacturing, holding several executive roles in Operations.
  • I see Rivian as the place where my aspirations will turn into reality.”
    “We’re incredibly excited about Carlo joining the team.

Outrider expands international hiring to support growth of autonomous, multi-robot systems in distribution yards

Retrieved on: 
Tuesday, September 26, 2023
Indian Army United Nations peacekeeping missions, University, Georgia Tech, University of Michigan, DL, Volvo, Sapienza University of Rome, Delft University of Technology, University of Cambridge, Deep learning, Uber, Stanford University, ETH Zurich, Intelligence, E-commerce, MIT, Harvard University, Organization, United States Army, RWTH Aachen University, NASA, Global 500, Carnegie Mellon University, IRobot, Waymo, Apple, Growth, EPFL, United Kingdom, Johns Hopkins, Purdue University, Tesla, Artificial intelligence, Safety, Lockheed Martin, Automation, Boeing, Engineering, Amazon, NVIDIA, Outrider, Northwestern

BRIGHTON, Colo., Sept. 26, 2023 /PRNewswire-PRWeb/ -- Outrider, the leader in autonomous yard operations for logistics hubs, announced it expanded its engineering workforce by 20% in Europe and Latin America to deliver its autonomous, multi-robot system. Through this expansion Outrider now has a global team of technical talent to support its 2024-2026 product strategy, including commercial expansion in 2024.

Key Points: 
  • Through this expansion Outrider now has a global team of technical talent to support its 2024-2026 product strategy, including commercial expansion in 2024.
  • With top talent from around the world, Outrider is accelerating the commercialization of its yard automation solution and supporting growth across its customers' logistics networks.
  • Recent international hiring has been focused on two critical areas: system safety for mixed-environment, large-scale autonomous solutions, and deep learning (DL) for distribution yards and other supply chain applications.
  • Each year, 20 billion tons of freight passes through distribution yards – the transition point between the warehouse and over-the-road trucking.

VASS strengthens its presence in Benelux and Greece with the appointment of Domenico Vaccaro as Managing Director

Retrieved on: 
Thursday, July 13, 2023
Growth, Private sector, University, Sapienza University of Rome, Computer, Computer engineering, VASS, Management

MADRID, July 13, 2023 /PRNewswire/ -- VASS, the leading digital solutions company, has appointed Domenico Vaccaro as Managing Director of Benelux and Greece. In this new role, Domenico will be responsible for leading VASS' value proposition, and driving its growth in both regions.

Key Points: 
  • The company appoints Domenico Vaccaro as Managing Director of Benelux and Greece to accelerate its growth in the region.
  • MADRID, July 13, 2023 /PRNewswire/ -- VASS, the leading digital solutions company, has appointed Domenico Vaccaro as Managing Director of Benelux and Greece.
  • In this new role, Domenico will be responsible for leading VASS' value proposition, and driving its growth in both regions.
  • "I am delighted to join VASS as Managing Director at this exciting time of the international expansion journey of company," said Domenico Vaccaro.

IAMA Therapeutics Announces Sponsored Research Agreement with The Sapienza University of Rome, Italy

Retrieved on: 
Monday, July 10, 2023
Research, Neurology, Clinical Trials, Biotechnology, Health, University, Pharmaceutical, Science, Education, Partnership, Central nervous system, Sapienza University of Rome, Epilepsy, Rett syndrome, IAMA, Dravet syndrome, DSM-IV codes, Patient, Deficit spending, NKCC1, Therapy, Physiology, Pharmaceutical industry, Pharmacology

IAMA Therapeutics, a pharmaceutical company focused on the discovery, development, and commercialization of novel medicines for children affected by brain disorders, today announced a partnership with The Sapienza University of Rome, Italy.

Key Points: 
  • IAMA Therapeutics, a pharmaceutical company focused on the discovery, development, and commercialization of novel medicines for children affected by brain disorders, today announced a partnership with The Sapienza University of Rome, Italy.
  • The planned translational study aims at investigating the functional efficacy of selective chloride modulators in reducing neuronal excitability and hippocampal activity in human tissue from patients with epilepsies and neurodevelopmental disorders, including Dravet syndrome, Focal Cortical Dysplasia, and Rett syndrome.
  • “We are excited to collaborate with the Sapienza University of Rome and Professor Eleonora Palma and Dr. Gabriele Ruffolo,” said Andrea P. Malizia, Ph.D., Chief Executive Officer at IAMA Therapeutics.
  • “Patients suffering from these disorders have unmet medical needs, and the discoveries resulting from this agreement could further advance potentially life-changing therapies for these children and their families.”

Celebrating a Dozen Years of Nurturing Growth: Alimentazione Bambini by Coop Marks its 12th Anniversary

Retrieved on: 
Tuesday, June 20, 2023
Nutrition, Obesity, University, Parent, Head, Coop, Publication, ECOG, Child, Sapienza University of Rome, Knowledge, Growth, Infant, University of Naples Federico II, Health, Weaning, Tutoring, Nursing, Pediatrics

Bologna, Italy, June 20, 2023 (GLOBE NEWSWIRE) -- As we celebrate the 12th anniversary of Alimentazione Bambini by Coop, we reflect on a journey filled with dedication, innovation, and a steadfast commitment to nurturing children’s growth.

Key Points: 
  • Bologna, Italy, June 20, 2023 (GLOBE NEWSWIRE) -- As we celebrate the 12th anniversary of Alimentazione Bambini by Coop, we reflect on a journey filled with dedication, innovation, and a steadfast commitment to nurturing children’s growth.
  • This service allows parents to seek advice from our expert medical team, making Alimentazione Bambini by Coop a trusted reference point for parents seeking guidance on child nutrition and health.
  • We’ve also been proud to provide hundreds of healthy and tasty recipes tailored to the nutritional needs of children.
  • This 12th anniversary is a testament to Alimentazione Bambini by Coop’s unwavering commitment to providing high-quality service.

Positive Results From Pivotal Trials of exa-cel for Transfusion-Dependent Beta Thalassemia and Severe Sickle Cell Disease Presented at the 2023 Annual European Hematology Association (EHA) Congress

Retrieved on: 
Friday, June 9, 2023
Stem Cells, Biometrics, Biotechnology, Pharmaceutical, General Health, Health, Genetics, Clinical Trials, CRISPR, Medical Affairs Bureau, Pediatrics, Hematology, Vertex, SCD, Quality of life, VOC, TI6, Congress, CRSP, Patient, Bambino, EHA, Sickle cell disease, Sapienza University of Rome, CRISPR Therapeutics, Therapy, TDT, Pediatric Hematology and Oncology, Safety, Vertex Pharmaceuticals, Pharmaceutical industry, Medical imaging

The results are being presented at the Annual European Hematology Association (EHA) Congress.

Key Points: 
  • The results are being presented at the Annual European Hematology Association (EHA) Congress.
  • The data shared are from 83 patients (48 with TDT and 35 with SCD) dosed with exa-cel with follow-up up to 43.7 months.
  • All patients treated with exa-cel demonstrated clinical benefit, and these data continue to demonstrate the potentially transformative profile of exa-cel.
  • This presentation will include updated pivotal trial data from patients treated with exa-cel in CLIMB-111 and CLIMB-121 and followed in CLIMB‑131.

Urologists Explore Online Educational Content, Erectile Dysfunction Drug Choices and Physical Therapy to Treat Premature Ejaculation

Retrieved on: 
Friday, April 28, 2023
Online, Systematic review, Abstract, LPE, Interview, Penis, Storey, Communication, Premature ejaculation, Case Western Reserve University School of Medicine, American Urological Association, Rehabilitation, Meta-analysis, Stanford University Medical Center, Assistant, PFM, MD, Sapienza University of Rome, Ejaculation, Coronary artery disease, Erectile dysfunction, Vita-Salute San Raffaele University, Birth control, Urology

Are there meaningful differences in drug choice for men with coronary artery disease and erectile dysfunction?

Key Points: 
  • Are there meaningful differences in drug choice for men with coronary artery disease and erectile dysfunction?
  • Researchers will be presenting these sexual health study findings at the 118th Annual Scientific Meeting of the American Urological Association.
  • "Long term follow-up outcomes of pelvic floor rehabilitation in subjects suffering from lifelong premature ejaculation: retrospective multicentre study."
  • Highlights include a study showing commonly prescribed erectile dysfunction treatments reduce life-threatening cardiovascular diseases, and another study utilizing physical therapy to treat premature ejaculation," said Dr. Bajic.

TELA Bio’s OviTex® Reinforced Tissue Matrix to be Featured in Three Case Reports at SAGES 2023

Retrieved on: 
Wednesday, March 29, 2023
Surgeon, Society, University, Society of American Gastrointestinal and Endoscopic Surgeons, Thoracic diaphragm, Florida State University, Anatomy, University of Florida, TAPP, MBA, Houston Methodist Hospital, MS, Report, Patient, Sapienza University of Rome, Matrix, FACS, Spigelian hernia, FICS, Treatment, MD

These case reports will help inform surgeons on techniques related to the use of OviTex in robot-assisted hernia repair.

Key Points: 
  • These case reports will help inform surgeons on techniques related to the use of OviTex in robot-assisted hernia repair.
  • OviTex Reinforced Tissue Matrix is uniquely positioned as a tissue-derived hernia reinforcement option that can be utilized successfully in robotic and laparoscopic hernia repairs.
  • “We’re excited and appreciative to see the use of OviTex in robotic hernia repair highlighted at SAGES,” said Antony Koblish, CEO of TELA Bio.
  • Florida State University, University of Florida)
    The TELA Bio team will be attending SAGES 2023, Booth #301.

Three VITAS® Healthcare Medical Directors Earn Fellow Status From AAHPM

Retrieved on: 
Wednesday, March 15, 2023
Palliative care, University of Sarajevo, Hospice, Booth, MD, AAHPM, Nature Coast, New York Medical College, VITAS Healthcare, American Academy, Patient, Sapienza University of Rome, HMDC, American Academy of Hospice and Palliative Medicine, VITAS, Flagler, University of Texas Southwestern Medical Center, University, Food delivery, Nursing

Fellowship status is bestowed after evaluation by their peers based on personal integrity, field knowledge, professional accomplishment and demonstrated scholarship, according to AAHPM.

Key Points: 
  • Fellowship status is bestowed after evaluation by their peers based on personal integrity, field knowledge, professional accomplishment and demonstrated scholarship, according to AAHPM.
  • Dr. Ismaili joined VITAS in 2008 as a team physician in Milwaukee, Wisconsin , and was promoted to medical director.
  • She earned her medical degree at the University of Texas Southwestern Medical Center in Dallas, Texas.
  • She earned her medical degree from Sapienza University of Rome in Italy after completing her first year of medical school at New York Medical College in Valhalla, New York.